- Primary research
- Open Access
Coping behaviors and depressive status in individuals with type 2 diabetes mellitus
Annals of General Psychiatryvolume 18, Article number: 11 (2019)
Type 2 diabetes mellitus (T2DM) is associated with a high prevalence of depression, which is influenced by personality traits and coping style. However, these psychological factors have not been well studied in individuals with T2DM. The association between coping behaviors and the reported levels of depressive symptoms was examined in individuals with T2DM.
The subjects were 435 T2DM patients (mean age 63.1 ± 12.6 years). Depressive status, personality traits and coping behaviors were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D) and the Brief Scale for Coping Profile (BSCP). Lifestyle factors and glycated hemoglobin A1c (HbA1c) levels in the patients were also included in the analyses.
Among the 435 subjects with T2DM, 130 (29.9%) exhibited possible depression, and 68 (15.6%) displayed probable depression. After adjustment for confounders, logistic and multiple regression analyses revealed that certain coping profile scores, such as Changing one’s point of view, Emotional expression involving others and Avoidance and suppression, were consistently and significantly associated with the presence and severity of depression. No relationship was found between depression and HbA1c.
These findings indicate that Maladaptive emotion-focused coping strategies, such as Emotional expression involving others and Avoidance and suppression, are protective factors and that Adaptive emotion-focused coping, such as Changing one’s point of view, is a risk factor for depression in T2DM patients. Psychological intervention focusing on the coping profile may reduce depressive symptoms. Additional studies are needed to examine the relationships between psychological factors and depressive symptoms using a longitudinal study design.
The high prevalence of type 2 diabetes mellitus (T2DM) as a lifestyle-related disease has become a burden, and T2DM can increase the risk of both serious physical and mental health issues. Depression is twice as common in patients with diabetes compared with the general population, with differing rates between patients with type 1 diabetes (21.3%) and T2DM (27.0%) . A recent meta-analysis suggested that the pooled relative risk for depression is 1.41–1.43 in patients with T2DM [2, 3].
Patients with diabetes have a variety of emotional reactions, such as shame, fear, shock and guilt . Notably, insulin therapy in particular may be associated with increased psychological distress . Emotional problems such as depression or diabetes-specific distress might complicate the required self-management of the disease  and limit the persons’ management of self-care activities (exercise, diet, rest) necessary to achieve adequate glycemic control [7,8,9,10].
A recent review reported that psychotherapeutic interventions (some of which were combined with diabetes education) had a moderate-to-large effect on depressive symptoms and a moderate-to-large effect on glycemic control. On the other hand, pharmacological treatment with selective serotonin reuptake inhibitor (SSRI) also had a moderate-to-large effect on depressive disorders but less of an effect on glycemic control. Therefore, the development of psychological intervention is important for the management of glycemic control.
The coping profile is a mediator that influences mood. Coping has been described as a process in which cognitive or behavioral strategies are developed to manage specific internal and/or external sources of psychological stress [11, 12]. The coping strategies used to address diabetes can play a key role in the maintenance and duration of the disease as well as the psychosocial adjustment to diabetes [13,14,15]. However, few studies have examined the potential link between coping behaviors and depressive symptoms among individuals with T2DM.
In the present study, we aimed to investigate the prevalence of depressive symptoms and to assess the relationship between coping behaviors and depressive symptoms among individuals with T2DM. We hypothesized that dysfunctional coping behaviors, such as Maladaptive emotion-focused coping strategies, would be associated with depressive symptoms.
This study was approved by the ethics committee of the Graduate School of Medicine, Hirosaki University, and written informed consent was obtained from each subject before participation in this study. A total of 728 individuals with T2DM who received treatment for at least 1 year at the Department of Endocrinology and Metabolism at the Hirosaki University Hospital were enrolled. We recruited 945 patients, and 728 agreed to take part in the study. The remaining 217 patients were excluded because of a decline (41 patients), moderate-to-severe dementia (85 patients), blindness (23 patients), or moderate-to-severe psychiatric diseases (e.g., schizophrenia and bipolar disorder; 68 patients).
A total of 611 out of 728 patients returned the questionnaires and were regarded as participants with informed consent, and the average (standard deviation) age, body mass index (BMI), CES-D and HbA1c were 63.5 (12.8) years, 24.9 (4.3), 13.3 (8.4) and 7.1 (0.9)%, respectively. Ultimately, 435 (59.7%) patients had complete questionnaires and were included as subjects in this study. No differences in demographic data were found between completers (n = 435) and noncompleters (n = 176). Routine glycated hemoglobin A1c (HbA1c) analysis was performed at least four times per year for these patients. Among the subjects, 385 were receiving an oral hypoglycemic agent, and 215 were receiving insulin therapy. The demographic data (age, sex, alcohol consumption, smoking, marital status, solitary living, and exercise habits) and medical histories of the patients were obtained from questionnaires and medical records.
The Japanese version of the Center for Epidemiologic Studies Depression Scale (CES-D) was administered to all of the participants to measure their depressive symptoms . The CES-D is a 20-item self-reported measure that focuses on the depressive symptoms the patient experienced during the week prior to completing the questionnaire. The maximum score is 60, with higher scores indicating more severe depressive symptoms. The standard cutoff score of − 16 for the CES-D had excellent sensitivity (91.3%) but low specificity (60.8%). A cutoff score of − 21 on the CES-D yielded an optimal balance between sensitivity (78.3%) and specificity (74.3%), with a positive predictive value (PPV) of 48.6% and a negative predictive value (NPV) of 91.7% . In addition, our previous study indicated that the stratum-specific likelihood ratios (SSLRs) were 0.13 (95% CI 0.04–0.40), 3.68 (95% CI 1.37–9.89), and 24.77 (95% CI 14.97–40.98) for CES-D scores of 0–16, 17–20, and above 21, respectively . Therefore, based on our previous study, a reported CES-D score of − 16 indicated possible depression, while a reported CES-D score of − 21 was indicative of probable depression.
The Brief Scale for Coping Profile (BSCP) was used to assess coping behaviors in the study. The BSCP consists of 18 items rated on a 4-point Likert scale [19,20,21]. We asked patients to check a box indicating the frequency at which they used the strategy described in a particular item in stressful situations using a scale from 1 (almost never) to 4 (very often). The scale assesses an individual’s ability to cope with stressful daily circumstances using six subscales: “Active solution (AC)”, “Seeking help for a solution (S)”, “Changing mood (CM)”, “Changing one’s point of view (CV)”, “Avoidance and suppression (AV)”and “Emotional expression involving others (EE)”. These six subscales reflect three different coping dimensions: problem-focused (AC and S), Adaptive emotion-focused (CM and CV), and Maladaptive emotion-focused (AV and EE) coping strategies. A high score on a certain subscale indicates that the respondent frequently selected that coping method.
In the present study, comparisons of several factors between patients with and without depression were performed using t-tests and Chi-square tests. The data are presented as the means ± standard deviations. A p-value < 0.05 indicated statistical significance. The factors associated with depression were examined using logistic regression analyses with forced entry; they included age, sex, BMI, HbA1c, presence/absence of smoking, habitual alcohol consumption, living alone, exercise habits, and insulin use, as well as each score for the 6 coping profiles or 3 coping dimensions. In addition, linear regression analyses with forced entry were performed to examine the correlation between the severity of depression (total CES-D scores) and several factors, including 3 coping dimensions. The dummy variables included were as follows: male = 1, female = 2, living with family = 0, living alone = 1, presence of spouse = 1, absence of spouse = 2, presence of smoking = 1, absence of smoking = 2, presence of alcohol consumption = 1, absence of alcohol consumption = 2, no exercise = 1, exercise once a week = 2, exercise 2–3 days per week = 3, exercise 4–5 days per week = 4, exercise almost every day = 5 and insulin nonuse = 0, insulin use = 1. A p-value < 0.05 indicated statistical significance. SPSS statistical software for Windows, version 25.0, was used for all analyses. A p < 0.0025 and a p < 0.0033 were regarded as significant using Bonferroni’s correction due to multiple testing in comparison between patients with and without depression and simple correlations, respectively.
Of the 435 patients, 130 (29.9%) had possible depression based on the standard CES-D cutoff value of 15.5. However, we designated 21.5 as the solid CES-D cutoff value, as previously described, and defined patients with CES-D scores of 21 and higher as showing depression. Thus, 64 (14.7%) patients exhibited probable depression.
Significant differences in BMI, smoking habits, Changing one’s point of view, Emotional expression involving others, and Avoidance and suppression were found between the patients with and without depression, but no differences in age, HbA1c, major lifestyle factors or marital status were observed (Table 1).
The logistic regression analysis that included patients with depression revealed associations with smoking habits, alcohol consumption habits, and Avoidance and suppression (Table 2). Multiple regression analysis indicated that BMI, smoking habits, alcohol consumption habits, marital status, Changing one’s point of view, Emotional expression involving others and Avoidance and suppression were correlated with the severity of depression as measured by the total CES-D score (Table 3).
The results of this study indicated that Avoidance and suppression, and Emotional expression involving others were inversely associated with depression and that Changing one’s point of view was significantly associated with depression in logistic regression analyses and linear regression analysis after adjustment for confounders. Among the coping dimension, Adaptive emotion-focused coping was negatively correlated with depression, and Maladaptive emotion-focused coping was significantly correlated with depression. In addition, depression was inversely associated with problem-focused coping dimensions such as Active solution or Seeking help for a solution in multiple regression analyses. This study is the first to investigate the relationship between coping profiles/dimensions and depression in T2DM. These findings indicate that Avoidance and suppression, and Emotional expression involving others, termed Maladaptive emotion-focused coping, are protective factors. Changing one’s point of view, termed Adaptive emotion-focused coping, is a risk factor for depression in T2DM patients. These findings were contradictory to our expectations that a functional coping style is considered protective, while a nonfunctional coping style is considered as a risk factor for depression.
In fact, a cross-sectional study  and longitudinal study  in Western populations consistently demonstrated that task-oriented coping was protective against depression, whereas emotional-oriented coping was a risk factor for depression. We cannot clearly explain this discrepancy, although one possible explanation could be the difference in not only demographics but also culture between Western and Asian countries. The participants in our sample were older and had more severe disease than those in previous studies [22, 23].
The differences between the results of this study and those of previous studies regarding the effect of coping strategy on depression may be indicative of cultural differences in how patients from various cultures distract or vent their diabetes-related distress [24,25,26]. In the Aomori region of Japan where this study was conducted, there are shaman called ITAKO or KAMISAMA who make predictions, tell fortunes and provide medical care through their spiritual or religious power . Out of 670 participants, 232 (34.6%) had experience consulting a shaman. Females had an increased tendency to consult shamans, and they went to shamans to address personal and family illness. Only 20% of the participants who visited shamans experienced no change, whereas the remaining participants felt healed. Thus, the subject may not have the stamina that is associated with protection against depression  but may have helplessness/hopelessness, which is a risk factor for depression . On the other hand, a Nigerian study showed that high religiosity is associated with positive coping skills . The discrepancy with previous studies may be explained by such spiritual or religious backgrounds . Several studies with various patient groups suggest that increased spiritual or religious coping decreases anxiety, hopelessness or depression in T2DM patients, and it stimulates psychological functions or quality of life [29,30,31]. Therefore, religiosity associated with coping style should be assessed in Japan, particularly in the Aomori region.
Similar to Avoidance and suppression, Denial is used in ‘an attempt to reject the reality of the stressful event’ . Denial is transiently effective in anxiety and/or depression, although it is thought to deteriorate anxiety and/or depression in the long term. However, patients with severe chronic disease may give up active coping gradually with the progression of diabetes-related conditions such as amputation or dialysis.
In the present study, the prevalence of possible and probable untreated depression among individuals with T2DM was 29.9% and 15.6%, respectively. The prevalence of depression in our study was within the range of previous results (15–43%) [33,34,35,36]. Untreated depression is associated with a higher number and increased the severity of physical and mental health comorbidities . Notably, the prevalence of depression in the study population was high compared to that in the general population in the same area. Depression is frequently combined with sleep problems , anxiety , and cardiovascular disease . Moreover, depression is often associated with risky health behaviors, such as poor diet, sedentariness and smoking, which result in obesity and diabetes . Therefore, the early detection of potential depression in individuals with T2DM is clinically important.
Our previous study, which included the same sample population as this study, demonstrated that an emotion-oriented coping style was associated with insomnia, a symptom of depression, as measured using the Pittsburgh Sleep Quality Index . Avoidance and suppression was a protective factor not only for depression in the current study but also for insomnia in the previous study.
This study has several notable limitations. First, the assessment of depressive symptoms was based on only the CES-D rather than clinician-administered structured diagnostic interviews based on established criteria, such as the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). The second limitation of this study was the recruitment strategy, which involved the recruitment of individuals with T2DM from the clinical setting of only one institute and excluded patients with severe mental illness, including major depressive disorders. The untreated individuals enrolled in the current study may not be representative of patients with clinical depression, and the severity of depressive symptoms among our participants might be lower than that among clinical T2DM patients. Third, data on several potential confounding factors, such as life events, economics, traumatic experiences and complications associated with T2DM, were not obtained because of strict ethical considerations and a reluctance to share medical information. This limitation is important because interpersonal relationships among family members and the severity of T2DM complications may have influenced the results of this study. In addition, 40% of the patients who responded to the questionnaire were excluded from the analysis. Because the sample comprised elderly patients, which suggests mild cognitive dysfunction among the participants, completing several kinds of questionnaires might be difficult. Therefore, the bias cannot be excluded entirely. Finally, this study is limited by its cross-sectional design; thus, we could not determine a causal relationship between coping behaviors/personality and the onset of depressive symptoms among the patients in our study population. A follow-up survey is needed to investigate these associations.
Avoidance and suppression, Emotional expression involving others and Changing one’s point of view were significantly associated with depressive symptoms. These findings indicate that coping behaviors may affect depressive symptoms among individuals with T2DM. Furthermore, T2DM patients might benefit from psycho-educational interventions, such as supportive psychotherapy; however, cognitive behavioral therapy, which is designed to help patients change their point of view and reduce their Avoidance and suppression behaviors when coping with the symptoms of their illness, may be harmful. Additional studies using a longitudinal study design are needed to examine the relationships between coping behaviors and depressive symptoms among T2DM patients.
Availability of data and materials
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.
Yu M, Zhang X, Lu F, Fang L. Depression and risk for diabetes. A meta-analysis. Can J Diabetes. 2015;39:266–72.
Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15:166–74.
Gask L, Dowrick C, Salmon P, Peters S, Morriss R. Reattribution reconsidered: narrative review and reflections on an educational intervention for medically unexplained symptoms in primary care settings. Psychosom Res. 2011;71:325–34.
Delahanty LM, Grant RW, Wittenberg E, Bosch JL, Wexler DJ, Cagliero E, et al. Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes. Diabet Med. 2007;24:48–54.
Aikens JE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care. 2012;35:2472–8.
Peyrot M, McMurry JF Jr, Kruger DF. A biopsychosocial model of glycemic control in diabetes: stress, coping and regimen adherence. J Health Soc Behav. 1999;40:141–58.
Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000–2002. Diabetes Care. 2005;28:1599–603.
Lloyd CE. Diabetes and mental health; the problem of co-morbidity. Diabet Med. 2010;27:853–4.
Lloyd CE, Nouwen A, Sartorius N, Ahmed HU, Alvarez A, Bahendeka S, et al. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabet Med. 2018;35:760–9.
Folkman S, Lazarus RS, Dunkel-Schetter C, DeLongis A, Gruen RJ. Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol. 1986;50:992–1003.
Folkman S, Lazarus RS. An analysis of coping in a middle-aged community sample. J Health Soc Behav. 1980;21:219–39.
Aldwin CM. Stress, coping and development: An integrative perspective. New York: Guilford Press; 1994.
Reid GJ, Dubow EF, Carey TC, Dura JR. Contribution of coping to medical adjustment and treatment responsibility among children and adolescents with diabetes. J Dev Behav Pediatr. 1994;15:327–35.
Graue M, Wentzel-Larsen T, Bru E, Hanestad BR, Sovik O. The coping styles of adolescents with type 1 diabetes are associated with degree of metabolic control. Diabetes Care. 2004;27:1313–7.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1997;1:385–401.
Zhang Y, Ting RZ, Lam MH, Lam SP, Yeung RO, Nan H, Ozaki R, et al. Measuring depression with CES-D in Chinese patients with type 2 diabetes: the validity and its comparison to PHQ-9. BMC Psychiatry. 2015;15:198.
Sugawara N, Kaneda A, Takahashi I, Nakaji S, Yasui-Furukori N. Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan. Neuropsychiatr Dis Treat. 2017;13:2369–74.
Kageyama T, Kobayashi T, Kawashima M, Kanamaru Y. Development of the Brief Scales for Coping Profile (BSCP) for workers: basic information about its reliability and validity. Sangyo Eiseigaku Zasshi. 2004;46:103–114 (in Japanese, Abstract in English).
Tomotsune Y, Sasahara S, Umeda T, Hayashi M, Usami K, Yoshino S, et al. The association of sense of coherence and coping profile with stress among research park city workers in Japan. Ind Health. 2009;47:664–72.
Sugawara N, Sato K, Takahashi I, Satake R, Fukuda S, Nakaji S, et al. Depressive symptoms and coping behaviors among individuals with irritable bowel syndrome in Japan. Intern Med. 2017;56:493–8.
Shah BM, Gupchup GV, Borrego ME, Raisch DW, Knapp KK. Depressive symptoms in patients with type 2 diabetes mellitus: do stress and coping matter? Stress Health. 2012;28:111–22.
Burns RJ, Deschênes SS, Schmitz N. Associations between coping strategies and mental health in individuals with type 2 diabetes: prospective analyses. Health Psychol. 2016;35:78–86.
Bjørkløf GH, Engedal K, Selbæk G, Kouwenhoven SE, Helvik AS. Coping and depression in old age: a literature review. Dement Geriatr Cogn Disord. 2013;35:121–54.
Thorpe CT, Fahey LE, Johnson H, Deshpande M, Thorpe JM, Fisher EB. Facilitating healthy coping in patients with diabetes: a systematic review. Diabetes Educ. 2013;39:33–52.
Fisher EB, Thorpe CT, Devellis BM, Devellis RF. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educ. 2007;33:1080–106.
Fujii H, Yamamoto H, Ohzeki N, Kadohara H, Sakae C, Abo M, et al. Shamanism and mental health in Aomori. J Aomori Univ Health Welf. 2002;4:79–87 (In Japanese).
Amadi KU, Uwakwe R, Odinka PC, Ndukuba AC, Muomah CR, Ohaeri JU. Religion, coping and outcome in out-patients with depression or diabetes mellitus. Acta Psychiatr Scand. 2016;133:489–96.
Peyrot MF, Mcmurry JF. Stress buffering and glycemic control—the role of coping styles. Diabetes Care. 1992;15:842–6.
Rubin RR, Payrot M. Psychological issues and treatments for people with diabetes. J Clin Psycho. 2001;57:457.
Rowe MM, Allen RG. Spirituality as a means of coping. Am J Health Studies. 2004;19:62–7.
Schmied EA, Padilla GA, Thomsen CJ, Lauby MD, Harris E, Taylor MK. Sex differences in coping strategies in military survival school. J Anxiety Disord. 2015;29:7–13.
Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care. 1993;16:1167–78.
Stahl D, Sum CF, Lum SS, Liow PH, Chan YH, Verma S, et al. Screening for depressive symptoms: validation of the center for epidemiologic studies depression scale (CES-D) in a multiethnic group of patients with diabetes in Singapore. Diabetes Care. 2008;31:1118–9.
Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142(Suppl):S8–21.
Zhang P, Lou P, Chang G, Chen P, Zhang L, Li T, Qiao C. Combined effects of sleep quality and depression on quality of life in patients with type 2 diabetes. BMC Fam Pract. 2016;17:40.
Ghio L, Gotelli S, Cervetti A, Respino M, Natta W, Marcenaro M, et al. Duration of untreated depression influences clinical outcomes and disability. J Affect Disord. 2015;175:224–8.
Tiller JW. Depression and anxiety. Med J Aust. 2013;199(6 Suppl):S28–31.
Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54:248–61.
Holt RI, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep. 2014;14:491.
Yoshida K, Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, et al. Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus. Neuropsychiatr Dis Treat. 2018;14:1803–9.
This study was funded by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Research JSPS, 15H04754 (Principal Investigator Norio Yasui-Furukori) and 15K01643 (Principal Investigator Hiroshi Murakami). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.
Ethics approval and consent to participate
Ethical approval was obtained from the ethics committee of the Graduate School of Medicine, Hirosaki University, Ref. 2015-002. The study purpose was explained to the participants. Written informed consent was provided by the respondents, based on their willingness to participate in the study. The parents or guardians of the minors provided written, informed consent for the minors to participate in the study.
Consent for publication
Norio Yasui-Furukori has been a speaker for Dainippon-Sumitomo Pharmaceutical, Mochida Pharmaceutical, and MSD. The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. The remaining authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.